Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miracle Fruit for Chemotherapy-Induced Dysgeusia
NCT04629560Phase 1Completed
- Sponsor
- Mount Sinai Medical Center
- Start
- Aug 2008
- Primary completion
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
Phase 1, randomised, open-label trial of synsepalum dulcificum in dysgeusia (2 arms), sponsored by Mount Sinai Medical Center. Primary endpoint: Incidence of taste alteration at 12 months. Started Aug 2008; status: completed.
02
Drugs
synsepalum dulcificum
03
Conditions
dysgeusia
Beyond the preview
Go deeper on NCT04629560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04629560.